Breast cancer could be detected up to five years before there are any clinical signs of it, using a blood test that identifies the body’s immune response to substances produced by tumour cells, according to new research presented at the 2019 NCRI Cancer Conference today (Sunday).
Cancer cells produce proteins called antigens that trigger the body to make antibodies against them – autoantibodies. Researchers at the University of Nottingham (UK) have found that these tumour-associated antigens (TAAs) are good indicators of cancer, and now they have developed panels of TAAs that are known already to be associated with breast cancer to detect whether or not there are autoantibodies against them in blood samples taken from patients.
In a pilot study the researchers, who are part of the Centre of Excellence for Autoimmunity in Cancer (CEAC) group at the School of Medicine, University of Nottingham, took blood samples from 90 breast cancer patients at the time they were diagnosed with breast cancer and matched them with samples taken from 90 patients without breast cancer (the control group).
They used screening technology (protein microarray) that allowed them to screen the blood samples rapidly for the presence of autoantibodies against 40 TAAs associated with breast cancer, and also 27 TAAs that were not known to be linked with the disease.
Presenting the research at the NCRI Conference, Ms Daniyah Alfattani, a PhD student in the group, said: “The results of our study showed that breast cancer does induce autoantibodies against panels of specific tumour-associated antigens. We were able to detect cancer with reasonable accuracy by identifying these autoantibodies in the blood.”
The researchers identified three panels of TAAs against which to test for autoantibodies. The accuracy of the test improved in the panels that contained more TAAs. The panel of five TAAs correctly detected breast cancer in 29% of the samples from the cancer patients and correctly identified 84% of the control samples as being cancer-free. The panel of seven TAAs correctly identified cancer in 35% of cancer samples and no cancer in 79% of control samples. The panel of nine antigens correctly identified cancer in 37% of cancer samples and no cancer in 79% of the controls.
“We need to develop and further validate this test,” said Ms Alfattani. “However, these results are encouraging and indicate that it’s possible to detect a signal for early breast cancer. Once we have improved the accuracy of the test, then it opens the possibility of using a simple blood test to improve early detection of the disease.”
The researchers are now testing samples from 800 patients against a panel of nine TAAs, and they expect the accuracy of the test to improve with these larger numbers.
“A blood test for early breast cancer detection would be cost effective, which would be of particular value in low and middle income countries. It would also be an easier screening method to implement compared to current methods, such as mammography,” said Ms Alfattani.
The researchers estimate that, with a fully-funded development programme, the test might become available in the clinic in about four to five years.
A similar test for lung cancer is currently being tested in a randomised controlled trial in Scotland, involving 12,000 people at high risk of developing lung cancer because they smoke. They have been randomised to have (or not) an autoantibody blood test called ELISA (Early CDT-Lung). Participants who test positive for the autoantibodies are then followed up with a CT scan every two years in order to detect lung cancer in its early stages when it is easier to treat.
The CEAC group is also working on similar tests for pancreatic, colorectal and liver cancers. Solid tumours like these, as well as lung and breast cancer, represent around 70% of all cancers.
“A blood test capable of detecting any of these cancers at an early stage is the over-riding objective of our work,” concluded Ms Alfattani.
Dr Iain Frame, CEO of NCRI said: “Early diagnosis using simple, non-invasive ways of detecting the first signs of cancer is a key strategic priority for NCRI and something we’d all like to see working in practice. The results from this pilot study for a blood test to detect early breast cancer are promising and build on this research group’s expertise in other cancers, such as lung cancer. It’s obviously early days but we look forward to seeing the results from the larger group of patients that are now being investigated.”
The Latest on: Breast cancer
[google_news title=”” keyword=”breast cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Breast cancer
- Return to work, work productivity loss and activity impairment in Chinese breast cancer survivors 12-month post-surgery: a longitudinal studyon February 22, 2024 at 8:35 pm
IntroductionExisting evidence of returning-to-work (RTW) after cancer comes predominately from Western settings, with none ...
- Kaitlyn Dever mourns mother's passing from breast cancer: 'Thank you for fighting so hard for us for so long'on February 22, 2024 at 9:14 am
Kaitlyn Dever mourns mother's passing from breast cancer: 'Thank you for fighting so hard for us for so long' ...
- Holiday House Tabletop Event returns Feb. 26 to Palm Beach to aid breast cancer researchon February 22, 2024 at 8:29 am
In its second year at The Colony Hotel, Monday’s charitable event for breast cancer research certainly has legs — although at least a few of those legs will likely be covered by tablecloths. No ...
- Proper serum levels of vitamin D may have a protective effect against breast canceron February 22, 2024 at 5:32 am
First, five studies were analyzed for the relationship between serum vitamin D levels and the risk of BC development; the optimal levels required for decreasing the risk were also evaluated. The team ...
- Why Kristen Dahlgren Left NBC To Advocate for Breast Cancer Vaccineson February 21, 2024 at 4:00 pm
“We've all been touched by breast cancer in some way. And we need everybody to be a part of this solution,” Kristen Dahlgren told CURE, regarding her decision to be a co-founder of the Pink Eraser ...
- A Black woman's breast cancer diagnosis led to a community of survivors embracing natural beauty productson February 21, 2024 at 10:18 am
Tiah Tomlin-Harris created an online support group in her hometown of Atlanta for other women on their cancer journey, called My Style Matters.
- I’m a breast cancer survivor in my 70s and I’m worried about dating againon February 21, 2024 at 4:56 am
I had a battle with breast cancer and had a mastectomy two years ago. I divorced a husband when I was 30, and it was the right thing to do because we were highly incompatible with different goals.I ...
- Study Finds Sisters of Women With High Breast Cancer Risk Share Common Factorson February 20, 2024 at 4:00 pm
Sisters of women with high breast cancer risk share similar risk factors, including high polygenic scores, benign breast disease history, and denser breast tissue. Women with high breast cancer risk ...
- Sarah Ferguson urges fans to 'be diligent' amid 2nd cancer diagnosis. What to know about breast cancer and melanomaon February 20, 2024 at 11:59 am
Sarah Ferguson, the Duchess of York, is urging people to be "diligent" with their health check-ups as she opens up about her second cancer diagnosis. The British author, 64, took to Instagram to mark ...
- Zeeland woman participates in potential game-changing breast cancer trialon February 20, 2024 at 12:54 am
ZEELAND — Last month, NBC News correspondent Kristen Dahlgren made headlines after announcing she was leaving the industry to launch a new organization, the Pink Eraser Project, committed to speeding ...
via Bing News